Archives: Contractor Email

Dear Colleague
Please find updated correspondence HERE from Chris Garland, Senior Principal Pharmaceutical Officer, Department of Health.

SUMMARY

  • The upcoming study aims to evaluate patient satisfaction with COVID-19 vaccination delivered via community pharmacy in Northern Ireland by measuring the reasons why patients choose to access vaccination from community pharmacy, patient attitudes to the service across three key quality domains (patient centeredness, professionalism and privacy), and overall satisfaction with the service.
  • The findings will be used to inform service developments and improvements for future vaccination campaigns. Further information on the study is detailed HERE.
ACTION
  • Contractors and pharmacists involved in the provision of this service are asked to review the correspondence.
  • If you wish to participate in the upcoming study, please reply to the updated email address x2u95@students.keele.ac.uk or before Friday 19 August 2022 to confirm your willingness to participate.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.

BSO ALERTS

CPNI ALERTS

DOH(NI) ALERTS

Please bring this to the attention of your pharmacy team(s).
Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar and Contractor Emails.

Or report medicine shortages, pricing and staffing issues via the CPNI’s Medicine Shortage Reporter and Situation Reporter.

Kind regards

SENT ON BEHALF OF 
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
Please find correspondence HERE from Chris Garland, Senior Principal Pharmaceutical Officer, Department of Health.

SUMMARY

  • The upcoming study aims to evaluate patient satisfaction with COVID-19 vaccination delivered via community pharmacy in Northern Ireland by measuring the reasons why patients choose to access vaccination from community pharmacy, patient attitudes to the service across three key quality domains (patient centeredness, professionalism and privacy), and overall satisfaction with the service.
  • The findings will be used to inform service developments and improvements for future vaccination campaigns. Further information on the study is detailed HERE.

ACTION

  • Contractors and pharmacists involved in the provision of this service are asked to review the correspondence.
  • If you wish to participate in the upcoming study, please reply to x2u95@keele.ac.uk or before Friday 19 August 2022 to confirm your willingness to participate.

Kind regards

SENT ON BEHALF OF
GERARD GREENE
Chief Executive
Dear Colleague
The final update of concessionary prices were granted today for July 2022:
DrugPack SizeConcessionary Price
Calcipotriol 0.005% / Betamethasone dipropionate
0.05% gel		60£36.13
Duloxetine 30mg gastro-resistant capsules28£4.28
Duloxetine 60mg gastro-resistant capsules28£6.91
Fluoxetine 20mg/5ml oral solution70£3.79
Risperidone 500microgram tablets20£2.57
Temazepam 10mg tablets28£17.00
Temazepam 20mg tablets28£18.22
Venlafaxine 75mg tablets56£12.86
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter.

Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
DR. GARETH C. GILVARY
Governance & Support Pharmacist
This update contains important information for community pharmacy teams, including details of the ongoing response to the COVID-19 pandemic.

BSO ALERTS

  • Weekly Drug Alerts are available here.
  • Weekly Shortages Information is available here.
  • Serious Shortage Protocols are available here.

CPNI ALERTS 

DOH(NI) ALERTS 

Please bring this to the attention of your pharmacy team(s).
Pharmacy team(s) can keep updated via CPNI’s Contractor Calendar or Contractor Emails

Or report medicine shortages, pricing and staffing issues via the CPNI’s Medicine Shortage Reporter or Situation Reporter

Kind regards

SENT ON BEHALF OF 
DR. GARETH C. GILVARY
Governance & Support Pharmacist
Dear Colleague
The fourth update of concessionary prices were granted today for July 2022:
DrugPack SizeConcessionary Price
Alendronic Acid 70mg tablets4£12.83
Aripiprazole 10mg tablets28£5.00
Aripiprazole 15mg tablets28£1.15
Aripiprazole 5mg tablets28£1.03
Bimatoprost 100micrograms/ml eye drops3£3.55
Chlorpromazine 100mg tablets28£25.04
Chlorpromazine 25mg tablets28£25.07
Chlorpromazine 50mg tablets28£25.73
Citalopram 10mg tablets28£2.48
Citalopram 20mg tablets28£3.83
Clarithromycin 500mg tablets14£7.32
Clonidine 25microgram tablets112£12.34
Dipyridamole 100mg tablets84£23.23
Enalapril 5mg tablets28£3.08
Esomeprazole 20mg gastro-resistant tablets28£5.78
Esomeprazole 40mg gastro-resistant tablets28£5.35
Exemestane 25mg tablets30£14.86
Finasteride 5mg tablets28£1.53
Fluoxetine 40mg capsules30£2.85
Gabapentin 600mg tablets100£5.57
Glyceryl trinitrate 500microgram sublingual tablets100£4.94
Hydroxocobalamin 1mg/1ml solution for injection
ampoules		5£6.77
Ibandronic acid 50mg tablets28£89.37
Lercanidipine 10mg tablets28£3.53
Losartan 50mg / Hydrochlorothiazide 12.5mg tablets28£5.73
Mometasone 0.1% cream100£8.84
Mometasone 0.1% cream30£3.73
Mometasone 0.1% ointment30£3.99
Phenoxymethylpenicillin 250mg tablets28£1.63
Prasugrel 10mg tablets28£8.65
Prednisolone 5mg soluble tablets30£17.74
Promethazine hydrochloride 10mg tablets56£13.45
Risedronate sodium 35mg tablets4£1.76
Tetracycline 250mg tablets28£7.06
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our new Medicine Shortage Reporter. Concessionary prices are also published on the CPNI website.

Kind regards

SENT ON BEHALF OF
DR. GARETH C. GILVARY
Governance & Support Pharmacist